Effects of Tryptophan Depletion on Brain Processing of Emotions in Patients With Mood Disorders
NCT00097175 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 95
Last updated 2019-12-12
Summary
This study will investigate how the brain process emotions in healthy people and in patients who have major depression in order to better understand the causes of depression. It will examine what happens in the brain when a person responds to words related to different emotions while the brain's ability to manufacture a chemical called serotonin is reduced. Serotonin regulates functions such as emotion, anxiety and sleep, and stress hormones such as cortisol. In this study, participants' serotonin levels are reduced by depleting tryptophan, an amino acid that is the main building block for serotonin.
Healthy volunteers and patients with major depression that has been in remission for at least 3 months may be eligible for this study. Candidates must be between 18 and 50 years of age and right-handed. They are interviewed about their medical and psychiatric history, current emotional state and sleep pattern, and family history of psychiatric disorders. Screening also includes psychiatric interviews and rating scales, neuropsychological tests, physical examination, electrocardiogram (EKG), and blood, urine, and saliva tests. Women have their menstrual phase determined by a blood test and home urine ovulation test kit.
The study involves two clinic visits in which participants undergo tryptophan depletion and magnetic resonance imaging (MRI). Subjects arrive at the NIH Clinical Center in the morning after fasting overnight. They fill out questionnaires have a blood sample drawn, and then take 74 capsules that contain a mixture of amino acids found in the diet. At one visit they are given capsules that contain a balanced mixture of amino acids one would normally eat in a day; at the other visit, some of the capsules contain lactose instead of tryptophan, causing tryptophan depletion. At 2 p.m. participants fill out the same questionnaires they completed at the beginning of the day and have another blood sample drawn. Then they do a computerized test in the MRI scanner. MRI uses a magnet and radio waves to obtain pictures of the brain. For the test, subjects lie on a narrow bed that slides into the cylindrical MRI scanner. They are asked to press a button in response to words associated with different emotions that appear on a screen. Arterial spin labeling - a test that uses magnetism to measure blood flow in different areas of the brain-is also done during the procedure. After the scan, subjects eat a meal and then return home.
DNA from the participants' blood samples is also examined to try to better understand the genetic causes of depression. Some of the white cells from the samples may also be grown in the laboratory so that additional studies can be done later.
...
Conditions
- Depressive Disorder, Major
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
lead NIH
Principal Investigators
-
Christian Grillon, Ph.D. · National Institute of Mental Health (NIMH)
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-11-10
- Completion
- 2014-01-15
Countries
- United States
Study Locations
More Related Trials
-
Brain Imaging of Serotonin Transporters in the Brain
NCT00059046 ·Status: COMPLETED
-
Dopamine Receptor Imaging in Mood Disorders
NCT00116077 ·Status: COMPLETED
-
Understanding Brain Reward Responses in Individuals With Major Depressive Disorder
NCT00183755 ·Status: COMPLETED
-
Decoding Emotional Dynamics in Bipolar Disorder
NCT07221864 ·Status: RECRUITING ·Phase: NA
-
Brain Mechanisms of Human Motivation
NCT01976975 ·Status: COMPLETED
-
Neuroimaging Study for Decoding Emotional States and Identifying Neural Circuits to Disengage From Negative Thinking
NCT06254144 ·Status: COMPLETED
-
Functional Neuroanatomy and Regional Metabolism Before and After Treatment With Duloxetine
NCT02658617 ·Status: COMPLETED
-
Identifying Cerebral Hemodynamic Patterns in Mood Disorders and Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy (fNIRS) Study
NCT06897670 ·Status: RECRUITING
-
Neuroimaging Sleep and Mood in Depression
NCT05497414 ·Status: UNKNOWN ·Phase: NA
-
A Multimodal Neuroimaging Study of Brain Activation Patterns Under Ketamine
NCT03609190 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Drugs on Cerebral Blood Flow in Patients With Mood Disorders
NCT00001478 ·Status: COMPLETED
-
Neurofeedback as a Treatment Tool for Depression
NCT01544205 ·Status: COMPLETED ·Phase: NA
-
Treating Emotional Processing Impairments in Individuals With TBI
NCT03373331 ·Status: UNKNOWN ·Phase: NA
-
Reward-Related Processes and Brain Function
NCT00029588 ·Status: COMPLETED
-
A Study To Investigate Effects Of GSK561679 On Brain Activation During Emotional Processing In Healthy Volunteers
NCT00513565 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Study 1.2 (Stress Manipulation)
NCT04325529 ·Status: ACTIVE_NOT_RECRUITING
-
Functional MRI Before and After Treatment for Depression
NCT00896441 ·Status: TERMINATED ·Phase: NA
-
Changes in the Brain as Borderline Patients Learn to Regulate Their Emotions
NCT02465697 ·Status: COMPLETED ·Phase: NA
-
Identifying Correlates of Brain Microglial Activation in Neuropsychiatric Syndromes: a Dimensional Approach
NCT03705715 ·Status: RECRUITING ·Phase: PHASE1
-
Study of Functional Networks in Resting fMRI
NCT03323073 ·Status: TERMINATED ·Phase: NA
-
Brain Chemical Receptor Effects in Patients With Panic Disorder and Post-Traumatic Stress Disorder
NCT00025974 ·Status: COMPLETED
-
Role of Dopamine, Serotonin and 5-HT2A Receptors in Emotion Processing
NCT03019822 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Affective Processing in Depression and Epilepsy
NCT00855725 ·Status: TERMINATED
-
Self Focus in Bipolar Disorder: A Functional Magnetic Resonance Imaging (fMRI) Study
NCT02253225 ·Status: COMPLETED
-
Neuro-computational Study of Thymic Fluctuations in Mood Disorders
NCT07033923 ·Status: RECRUITING ·Phase: NA